Rehabilitation Decreases Spasticity by Restoring Chloride Homeostasis through the Brain-Derived Neurotrophic Factor–KCC2 Pathway after Spinal Cord Injury
Restricted accessResearch articleFirst published online March, 2020
Rehabilitation Decreases Spasticity by Restoring Chloride Homeostasis through the Brain-Derived Neurotrophic Factor–KCC2 Pathway after Spinal Cord Injury
Activity-based therapy is routinely integrated in rehabilitation programs to facilitate functional recovery after spinal cord injury (SCI). Among its beneficial effects is a reduction of hyperreflexia and spasticity, which affects ∼75% of the SCI population. Unlike current anti-spastic pharmacological treatments, rehabilitation attenuates spastic symptoms without causing an active depression in spinal excitability, thus avoiding further interference with motor recovery. Understanding how activity-based therapies contribute to decrease spasticity is critical to identifying new pharmacological targets and to optimize rehabilitation programs. It was recently demonstrated that a decrease in the expression of KCC2, a neuronal Cl– extruder, contributes to the development spasticity in SCI rats. Although exercise can decrease spinal hyperexcitability and increase KCC2 expression on lumbar motoneurons after SCI, a causal effect remains to be established.
Activity-dependent processes include an increase in brain-derived neurotrophic factor (BDNF) expression. Interestingly, BDNF is a regulator of KCC2 but also a potent modulator of spinal excitability. Therefore, we hypothesized that after SCI, the activity-dependent increase in KCC2 expression: 1) functionally contributes to reduce hyperreflexia, and 2) is regulated by BDNF. SCI rats chronically received VU0240551 (KCC2 blocker) or TrkB-IgG (BDNF scavenger) during the daily rehabilitation sessions and the frequency-dependent depression of the H-reflex, a monitor of hyperreflexia, was recorded 4 weeks post-injury. Our results suggest that the activity-dependent increase in KCC2 functionally contributes to H-reflex recovery and critically depends on BDNF activity. This study provides a new perspective in understanding how exercise impacts hyperreflexia by identifying the biological basis of the recovery of function.
Get full access to this article
View all access options for this article.
References
1.
DietzV. (2001). Spinal cord lesion: effects of and perspectives for treatment. Neural Plast. 8, 83–90.
2.
PetropoulouK.B., PanouriasI.G., RapidiC.A., and SakasD.E. (2007). The importance of neurorehabilitation to the outcome of neuromodulation in spasticity. Acta Neurochir Suppl. 97, 243–250.
3.
MaynardF.M., KarunasR.S., and WaringW.P., 3rd. (1990). Epidemiology of spasticity following traumatic spinal cord injury. Arch. Phys. Med. Rehabil. 71, 566–569.
4.
SkoldC., LeviR., and SeigerA. (1999). Spasticity after traumatic spinal cord injury: nature, severity, and location. Arch. Phys. Med. Rehabil. 80, 1548–1557.
5.
HoltzK.A., LipsonR., NoonanV.K., KwonB.K., and MillsP.B. (2017). Prevalence and effect of problematic spasticity after traumatic spinal cord injury. Arch. Phys. Med. Rehabil. 98, 1132–1138.
6.
DarioA., and TomeiG. (2004). A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf. 27, 799–818.
7.
AdamsM.M., and HicksA.L. (2005). Spasticity after spinal cord injury. Spinal Cord, 43, 577–586.
8.
ElbasiounyS.M., MorozD., BakrM.M., and MushahwarV.K. (2010). Management of spasticity after spinal cord injury: current techniques and future directions. Neurorehabil. Neural Repair, 24, 23–33.
9.
AngeliC., OchsnerJ., and HarkemaS. (2012). Effects of chronic baclofen use on active movement in an individual with a spinal cord injury. Spinal Cord, 50, 925–927.
BoyceV.S., and MendellL.M. (2014). Neurotrophins and spinal circuit function. Front. Neural Circuits, 8, 59.
12.
BoyceV.S., and MendellL.M. (2014). Neurotrophic factors in spinal cord injury. Handb. Exp. Pharmacol. 220, 443–460.
13.
LeechK.A., and HornbyT.G. (2017). High-intensity locomotor exercise increases brain-derived neurotrophic factor in individuals with incomplete spinal cord injury. J. Neurotrauma, 34, 1240–1248.
14.
HutchinsonK.J., Gomez-PinillaF., CroweM.J., YingZ., and BassoD.M. (2004). Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain, 127, 1403–1414.
15.
BeaumontE., KaloustianS., RousseauG., and CormeryB. (2008). Training improves the electrophysiological properties of lumbar neurons and locomotion after thoracic spinal cord injury in rats. Neurosci. Res. 62, 147–154.
16.
YingZ., RoyR.R., ZhongH., ZdunowskiS., EdgertonV.R., and Gomez-PinillaF. (2008). BDNF-exercise interactions in the recovery of symmetrical stepping after a cervical hemisection in rats. Neuroscience, 155, 1070–1078.
17.
CôtéM.-P., AzzamG.A., LemayM.A., ZhukarevaV., and HouleJ.D. (2011). Activity-dependent increase in neurotrophic factors is associated with an enhanced modulation of spinal reflexes after spinal cord injury. J. Neurotrauma, 28, 299–309.
18.
RiveraC., LiH., Thomas-CrusellsJ., LahtinenH., ViitanenT., NanobashviliA., KokaiaZ., AiraksinenM.S., VoipioJ., KailaK., and SaarmaM. (2002). BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion. J. Cell Biol. 159, 747–752.
19.
RiveraC., VoipioJ., Thomas-CrusellsJ., LiH., EmriZ., SipilaS., PayneJ.A., MinichielloL., SaarmaM., and KailaK. (2004). Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2. J. Neurosci. 24, 4683–4691.
20.
CoullJ.A., BeggsS., BoudreauD., BoivinD., TsudaM., InoueK., GravelC., SalterM.W., and DeK.Y. (2005). BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 438, 1017–1021.
21.
MileticG., and MileticV. (2008). Loose ligation of the sciatic nerve is associated with TrkB receptor-dependent decreases in KCC2 protein levels in the ipsilateral spinal dorsal horn. Pain, 137, 532–539.
22.
FerriniF., TrangT., MattioliT.A., LaffrayS., Del'GuidiceT., LorenzoL.E., CastonguayA., DoyonN., ZhangW., GodinA.G., MohrD., BeggsS., VandalK., BeaulieuJ.M., CahillC.M., SalterM.W., and De KoninckY. (2013). Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl(-) homeostasis. Nat. Neurosci. 16, 183–192.
23.
LuY., ZhengJ., XiongL., ZimmermannM. and YangJ. (2008). Spinal cord injury-induced attenuation of GABAergic inhibition in spinal dorsal horn circuits is associated with down-regulation of the chloride transporter KCC2 in rat. J.Physiol. 586, 5701–5715.
24.
BoulenguezP., LiabeufS., BosR., BrasH., Jean-XavierC., BrocardC., StilA., DarbonP., CattaertD., DelpireE., MarsalaM., and VinayL. (2010). Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury. Nat. Med. 16, 302–307.
25.
GackiereF., and VinayL. (2015). Contribution of the potassium-chloride cotransporter KCC2 to the strength of inhibition in the neonatal rodent spinal cord in vitro. J. Neurosci. 35, 5307–5316.
26.
CôtéM.-P., GandhiS., ZambrottaM., and HouleJ.D. (2014). Exercise modulates chloride homeostasis after spinal cord injury. J. Neurosci. 34, 8976–8987.
27.
ChopekJ.W., SheppardP.C., GardinerK., and GardinerP.F. (2015). Serotonin receptor and KCC2 gene expression in lumbar flexor and extensor motoneurons posttransection with and without passive cycling. J. Neurophysiol. 113, 1369–1376.
28.
TashiroS., ShinozakiM., MukainoM., Renault-MiharaF., ToyamaY., LiuM., NakamuraM., and OkanoH. (2015). BDNF induced by treadmill training contributes to the suppression of spasticity and allodynia after spinal cord injury via upregulation of KCC2. Neurorehabil. Neural Repair, 29, 677–689.
29.
AguadoF., CarmonaM.A., PozasE., AguiloA., Martinez-GuijarroF.J., AlcantaraS., BorrellV., YusteR., IbanezC.F., and SorianoE. (2003). BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2. Development, 130, 1267–1280.
30.
LudwigA., UvarovP., SoniS., Thomas-CrusellsJ., AiraksinenM.S., and RiveraC. (2011). Early growth response 4 mediates BDNF induction of potassium chloride cotransporter 2 transcription. J. Neurosci. 31, 644–649.
31.
KailaK., PriceT.J., PayneJ.A., PuskarjovM., and VoipioJ. (2014). Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat. Rev. Neurosci. 15, 637–654.
32.
KailaK., RuusuvuoriE., SejaP., VoipioJ., and PuskarjovM. (2014). GABA actions and ionic plasticity in epilepsy. Curr. Opin. Neurobiol. 26, 34–41.
33.
KhirugS., AhmadF., PuskarjovM., AfzalovR., KailaK., and BlaesseP. (2010). A single seizure episode leads to rapid functional activation of KCC2 in the neonatal rat hippocampus. J. Neurosci. 30, 12028–12035.
34.
PuskarjovM., AhmadF., KhirugS., SivakumaranS., KailaK., and BlaesseP. (2015). BDNF is required for seizure-induced but not developmental up-regulation of KCC2 in the neonatal hippocampus. Neuropharmacology, 88, 103–109.
35.
TanT., WattsS.W., and DavisR.P. (2011). Drug delivery: enabling technology for drug discovery and development. iPRECIO Micro Infusion Pump: programmable, refillable, and implantable. Front. Pharmacol. 2, 44.
36.
Gomez-PinillaF., HuieJ.R., YingZ., FergusonA.R., CrownE.D., BaumbauerK.M., EdgertonV.R., and GrauJ.W. (2007). BDNF and learning: evidence that instrumental training promotes learning within the spinal cord by up-regulating BDNF expression. Neuroscience, 148, 893–906.
37.
AustinT.M., and DelpireE. (2011). Inhibition of KCC2 in mouse spinal cord neurons leads to hypersensitivity to thermal stimulation. Anesth. Analg. 113, 1509–1515.
38.
FordA., CastonguayA., CottetM., LittleJ.W., ChenZ., Symons-LiguoriA.M., DoyleT., EganT.M., VanderahT.W., De KoninckY., ToshD.K., JacobsonK.A., and SalveminiD. (2015). Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain. J. Neurosci. 35, 6057–6067.
39.
HouleJ.D., MorrisK., SkinnerR.D., Garcia-RillE., and PetersonC.A. (1999). Effects of fetal spinal cord tissue transplants and cycling exercise on the soleus muscle in spinalized rats. Muscle Nerve, 22, 846–856.
40.
LiabeufS., Stuhl-GourmandL., GackiereF., MancusoR., Sanchez BruallaI., MarinoP., BrocardF., and VinayL. (2017). Prochlorperazine increases KCC2 function and reduces spasticity after spinal cord injury. J. Neurotrauma, 34, 3397–3406.
41.
BennettD.J., GorassiniM., FouadK., SanelliL., HanY., and ChengJ. (1999). Spasticity in rats with sacral spinal cord injury. J. Neurotrauma, 16, 69–84.
42.
YatesC., CharlesworthA., AllenS.R., ReeseN.B., SkinnerR.D., and Garcia-RillE. (2008). The onset of hyperreflexia in the rat following complete spinal cord transection. Spinal Cord, 46, 798–803.
43.
ThompsonF.J., ReierP.J., LucasC.C., and ParmerR. (1992). Altered patterns of reflex excitability subsequent to contusion injury of the rat spinal cord. J. Neurophysiol. 68, 1473–1486.
44.
GreyM.J., KlingeK., CroneC., LorentzenJ., Biering-SorensenF., RavnborgM., and NielsenJ.B. (2008). Post-activation depression of soleus stretch reflexes in healthy and spastic humans. Exp. Brain Res. 185, 189–197.
45.
FerriniF., and De KoninckY. (2013). Microglia control neuronal network excitability via BDNF signalling. Neural. Plast. 2013, 429815.
46.
CramerS.W., BaggottC., CainJ., TilghmanJ., AllcockB., MiranpuriG., RajpalS., SunD., and ResnickD. (2008). The role of cation-dependent chloride transporters in neuropathic pain following spinal cord injury. Mol. Pain, 4, 36.
47.
HasbargenT., AhmedM.M., MiranpuriG., LiL., KahleK.T., ResnickD., and SunD. (2010). Role of NKCC1 and KCC2 in the development of chronic neuropathic pain following spinal cord injury. Ann. N.Y. Acad. Sci. 1198, 168–172.
48.
LeeH.K., AhmedM.M., KingK.C., MiranpuriG.S., KahleK.T., ResnickD.K., and SunD. (2014). Persistent phosphorylation of NKCC1 and WNK1 in the epicenter of the spinal cord following contusion injury. Spine, J14, 777–781.
49.
BehrmanA.L., and HarkemaS.J. (2000). Locomotor training after human spinal cord injury: a series of case studies. Phys.Ther. 80, 688–700.
50.
JonesM.L., HarnessE., DenisonP., TefertillerC., EvansN., and LarsonC.A. (2012). Activity-based therapies in spinal cord injury: clinical focus and empirical evidence in three independent programs. Top Spinal Cord Inj. Rehabil. 18, 34–42.
51.
TillakaratneN.J., MouriaM., ZivN.B., RoyR.R., EdgertonV.R., and TobinA.J. (2000). Increased expression of glutamate decarboxylase (GAD(67)) in feline lumbar spinal cord after complete thoracic spinal cord transection. J. Neurosci. Res. 60, 219–230.
52.
TillakaratneN.J., De LeonR.D., HoangT.X., RoyR.R., EdgertonV.R., and TobinA.J. (2002). Use-dependent modulation of inhibitory capacity in the feline lumbar spinal cord. J. Neurosci. 22, 3130–3143.
KhristyW., AliN.J., BravoA.B., de LeonR., RoyR.R., ZhongH., LondonN.J., EdgertonV.R., and TillakaratneN.J. (2009). Changes in GABA(A) receptor subunit gamma 2 in extensor and flexor motoneurons and astrocytes after spinal cord transection and motor training. Brain Res. 1273, 9–17.
55.
HartB.L. (1971). Facilitation by strychnine of reflex walking in spinal dogs. Physiol. Behav. 6, 627–628.
56.
RobinsonG.A., and GoldbergerM.E. (1986). The development and recovery of motor function in spinal cats. II. Pharmacological enhancement of recovery. Exp. Brain Res. 62, 387–400.
57.
De LeonR.D., HodgsonJ.A., RoyR.R., and EdgertonV.R. (1999). Retention of hindlimb stepping ability in adult spinal cats after the cessation of step training. J. Neurophysiol. 81, 85–94.
58.
HubnerC.A., SteinV., Hermans-BorgmeyerI., MeyerT., BallanyiK., and JentschT.J. (2001). Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron, 30, 515–524.
59.
Jean-XavierC., PfliegerJ.F., LiabeufS., and VinayL. (2006). Inhibitory postsynaptic potentials in lumbar motoneurons remain depolarizing after neonatal spinal cord transection in the rat. J. Neurophysiol. 96, 2274–2281.
60.
BosR., SadlaoudK., BoulenguezP., ButtigiegD., LiabeufS., BrocardC., HaaseG., BrasH., and VinayL. (2013). Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2. Proc. Natl. Acad. Sci. U S A, 110, 348–353.
61.
ModolL., MancusoR., AleA., Francos-QuijornaI., and NavarroX. (2014). Differential effects on KCC2 expression and spasticity of ALS and traumatic injuries to motoneurons. Front. Cell Neurosci. 8, 7.
62.
LeeH.H., WalkerJ.A., WilliamsJ.R., GoodierR.J., PayneJ.A., and MossS.J. (2007). Direct protein kinase C-dependent phosphorylation regulates the cell surface stability and activity of the potassium chloride cotransporter KCC2. J. Biol. Chem. 282, 29777–29784.
63.
ChenB., LiY., YuB., ZhangZ., BrommerB., WilliamsP.R., LiuY., HegartyS.V., ZhouS., ZhuJ., GuoH., LuY., ZhangY., GuX., and HeZ. (2018). Reactivation of dormant relay pathways in injured spinal cord by KCC2 manipulations. Cell, 174, 521–535, e513.
64.
Lee-KubliC.A., and CalcuttN.A. (2014). Altered rate-dependent depression of the spinal H-reflex as an indicator of spinal disinhibition in models of neuropathic pain. Pain, 155, 250–260.
65.
JolivaltC.G., LeeC.A., RamosK.M., and CalcuttN.A. (2008). Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain, 140, 48–57.
66.
CoullJ.A., BoudreauD., BachandK., PrescottS.A., NaultF., SikA., DeK.P., and DeK.Y. (2003). Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature, 424, 938–942.
67.
PayneJ.A., RiveraC., VoipioJ., and KailaK. (2003). Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci. 26, 199–206.
68.
NabekuraJ., UenoT., OkabeA., FurutaA., IwakiT., Shimizu-OkabeC., FukudaA., and AkaikeN. (2002). Reduction of KCC2 expression and GABAA receptor-mediated excitation after in vivo axonal injury. J, Neurosci. 22, 4412–4417.
69.
YanY., DempseyR.J., and SunD. (2001). Na+-K+-Cl- cotransporter in rat focal cerebral ischemia. J. Cereb. Blood Flow Metab. 21, 711–721.
70.
FiumelliH., and WoodinM.A. (2007). Role of activity-dependent regulation of neuronal chloride homeostasis in development. Curr. Opin. Neurobiol. 17, 81–86.
CarmonaM.A., PozasE., MartinezA., Espinosa-ParrillaJ.F., SorianoE., and AguadoF. (2006). Age-dependent spontaneous hyperexcitability and impairment of GABAergic function in the hippocampus of mice lacking trkB. Cereb. Cortex, 16, 47–63.
73.
BoyceV.S., TumoloM., FischerI., MurrayM., and LemayM.A. (2007). Neurotrophic factors promote and enhance locomotor recovery in untrained spinalized cats. J. Neurophysiol. 98, 1988–1996.
74.
BoyceV.S., ParkJ., GageF.H., and MendellL.M. (2012). Differential effects of brain-derived neurotrophic factor and neurotrophin-3 on hindlimb function in paraplegic rats. Eur. J. Neurosci. 35, 221–232.
75.
HuieJ.R., GarrawayS.M., BaumbauerK.M., HoyK.C.Jr., BeasB.S., MontgomeryK.S., BizonJ.L., and GrauJ.W. (2012). Brain-derived neurotrophic factor promotes adaptive plasticity within the spinal cord and mediates the beneficial effects of controllable stimulation. Neuroscience, 200, 74–90.
76.
ZadranS., JourdiH., RostamianiK., QinQ., BiX., and BaudryM. (2010). Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation. J. Neurosci. 30, 1086–1095.
77.
ZhouH.Y., ChenS.R., ByunH.S., ChenH., LiL., HanH.D., Lopez-BeresteinG., SoodA.K., and PanH.L. (2012). N-methyl-D-aspartate receptor- and calpain-mediated proteolytic cleavage of K+-Cl- cotransporter-2 impairs spinal chloride homeostasis in neuropathic pain. J. Biol. Chem. 287, 33853–33864.
78.
PuskarjovM., AhmadF., KailaK., and BlaesseP. (2012). Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain. J. Neurosci. 32, 11356–11364.
79.
BrocardC., PlantierV., BoulenguezP., LiabeufS., BouhadfaneM., Viallat-LieutaudA., VinayL., and BrocardF. (2016). Cleavage of Na(+) channels by calpain increases persistent Na(+) current and promotes spasticity after spinal cord injury. Nat. Med. 22, 404–411.
80.
PlantierV., and BrocardF. (2017). [Calpain as a new therapeutic target for treating spasticity after a spinal cord injury]. Med. Sci. (Paris) 33, 629–636.
81.
KanakaC., OhnoK., OkabeA., KuriyamaK., ItohT., FukudaA., and SatoK. (2001). The differential expression patterns of messenger RNAs encoding K-Cl cotransporters (KCC1,2) and Na-K-2Cl cotransporter (NKCC1) in the rat nervous system. Neuroscience, 104, 933–946.
82.
StilA., LiabeufS., Jean-XavierC., BrocardC., ViemariJ.C., and VinayL. (2009). Developmental up-regulation of the potassium-chloride cotransporter type 2 in the rat lumbar spinal cord. Neuroscience, 164, 809–821.
83.
KahleK.T., RinehartJ., and LiftonR.P. (2010). Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases. Biochim. Biophys. Acta, 1802, 1150–1158.
84.
AlessiD.R., ZhangJ., KhannaA., HochdorferT., ShangY., and KahleK.T. (2014). The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters. Sci. Signal 7,re3.
85.
FriedelP., KahleK.T., ZhangJ., HertzN., PisellaL.I., BuhlerE., SchallerF., DuanJ., KhannaA.R., BishopP.N., ShokatK.M., and MedinaI. (2015). WNK1-regulated inhibitory phosphorylation of the KCC2 cotransporter maintains the depolarizing action of GABA in immature neurons. Sci. Signal 8,ra65.
86.
KahleK.T., SchmouthJ.F., LavastreV., LatremoliereA., ZhangJ., AndrewsN., OmuraT., LaganiereJ., RochefortD., HinceP., CastonguayG., GaudetR., MapplebeckJ.C., SotocinalS.G., DuanJ., WardC., KhannaA.R., MogilJ.S., DionP.A., WoolfC.J., InquimbertP., and RouleauG.A. (2016). Inhibition of the kinase WNK1/HSN2 ameliorates neuropathic pain by restoring GABA inhibition. Sci. Signal 9,ra32.
87.
BoormanG.I., LeeR.G., BeckerW.J., and WindhorstU.R. (1996). Impaired “natural reciprocal inhibition”. in patients with spasticity due to incomplete spinal cord injury. Electroencephalogr. Clin. Neurophysiol. 101, 84–92.
88.
MazzocchioR., and RossiA. (1997). Involvement of spinal recurrent inhibition in spasticity. Further insight into the regulation of Renshaw cell activity. Brain 120 (Pt. 6), 991–1003.
89.
KatzR. (1999). Presynaptic inhibition in humans: a comparison between normal and spastic patients. J. Physiol. Paris, 93, 379–385.
90.
HarkemaS.J. (2008). Plasticity of interneuronal networks of the functionally isolated human spinal cord. Brain Res. Rev. 57, 255–264.
91.
WeishauptN., BleschA., and FouadK. (2012). BDNF: the career of a multifaceted neurotrophin in spinal cord injury. Exp. Neurol. 238, 254–264.
92.
FouadK., BennettD.J., VavrekR., and BleschA. (2013). Long-term viral brain-derived neurotrophic factor delivery promotes spasticity in rats with a cervical spinal cord hemisection. Front. Neurol. 4, 187.
93.
DoyonN., FerriniF., GagnonM., and De KoninckY. (2013). Treating pathological pain: is KCC2 the key to the gate?. Expert Rev. Neurother. 13, 469–471.
94.
GagnonM., BergeronM.J., LavertuG., CastonguayA., TripathyS., BoninR.P., Perez-SanchezJ., BoudreauD., WangB., DumasL., ValadeI., BachandK., Jacob-WagnerM., TardifC., KianickaI., IsenringP., AttardoG., CoullJ.A., and De KoninckY. (2013). Chloride extrusion enhancers as novel therapeutics for neurological diseases. Nat. Med. 19, 1524–1528.
95.
FerriniF., LorenzoL.E., GodinA.G., QuangM.L., and De KoninckY. (2017). Enhancing KCC2 function counteracts morphine-induced hyperalgesia. Sci. Rep. 7, 3870.
